论文部分内容阅读
目的观察胺碘酮注射液治疗急性心力衰竭(心衰)并快速心律失常的临床疗效。方法 100例急性心衰并快速心律失常患者,按照随机数字法分为观察组与对照组,每组50例。对照组患者行常规抗心衰治疗,观察组患者在此基础上联合药物胺碘酮注射液治疗。分析两组患者的临床治疗效果。结果观察组治疗有效率为92%;对照组为70%,组间比较差异具有统计学意义(P<0.05);观察组不良反应发生率为12%,对照组为10%,比较差异无统计学意义(P>0.05)。结论在常规治疗基础上联合胺碘酮注射液治疗急性心衰并心律失常临床效果显著,值得临床推广。
Objective To observe the clinical efficacy of amiodarone in the treatment of acute heart failure (HF) and tachyarrhythmia. Methods 100 patients with acute heart failure and tachyarrhythmia were divided into observation group and control group according to random number method, with 50 cases in each group. Patients in the control group were treated with conventional anti-heart failure, and patients in the observation group were treated with amiodarone injection on the basis of the above. Analysis of two groups of patients with clinical treatment. Results The effective rate was 92% in the observation group and 70% in the control group, with significant difference between the two groups (P <0.05). The adverse reaction rate was 12% in the observation group and 10% in the control group, with no statistical difference Significance (P> 0.05). Conclusion The combination of amiodarone injection on the basis of routine treatment of acute heart failure and arrhythmia clinical effect is significant, worthy of clinical promotion.